Endocrinology
Conference Coverage
Learn ‘four Ds’ approach to heart failure in diabetes
Heart failure in the presence of type 2 diabetes has a 5-year survival rate on par with some of the worst diseases.
Conference Coverage
How to prioritize CVD reduction in type 2 diabetes
The paradigm of treating patients with type 2 diabetes should shift from a narrow focus on hemoglobin A1c control.
From the Journals
Iodine deficiency linked to delay in pregnancy
“The significant delay in time to pregnancy in that group raises serious concerns,” wrote James L. Mills, MD, of the NICHD.
From the Journals
Hormone therapy may reduce depressive symptoms in early menopause
Women in the placebo arm were more than twice as likely to score at least 16 on the Center for Epidemiologic Studies–Depression Scale.
Latest News
Systemic corticosteroids not recommended for long-term treatment of eczema
The adverse effects of systemic corticosteroids for atopic dermatitis are of particular concern due to the potential for growth retardation in...
Conference Coverage
New and improved classifiers may sharpen thyroid nodule diagnosis
VICTORIA, B.C. – The tests could improve preoperative assessment, even in histologic subsets that pose diagnostic challenges.
From the Journals
Don’t choose hormones to protect postmenopausal women
The USPSTF has issued a recommendation against using estrogen or estrogen plus progestin to prevent chronic conditions in postmenopausal women.
Conference Coverage
E-health app helps weight loss, QOL for African American breast cancer survivors
MONTREAL – Overall, but not cancer-related, quality of life improved significantly for participants.
Conference Coverage
Analysis strengthens association between epilepsy onset, menarche
WASHINGTON – Adrenarche encompasses the period of risk.
Conference Coverage
Large database analysis suggests safety of bariatric surgery in seniors
The risk may be considered acceptable in relation to the potential health benefits.
Conference Coverage
Ulipristal acetate reduced bleeding for women with fibroids
SAN ANTONIO – About half of women in the VENUS II study achieved amenorrhea.